Impact immediate treatment interruption of secukinumab efficacy in patients with active psoriatic arthritis and ankylosing spondylitis: interim analysis results from the SERENA study
Gullick, Nicola Gullick, Nicola
Gullick, Nicola
Gullick, Nicola
Citations
Altmetric:
Affiliation
11. Gaffney K, Kiltz U, Sfikakis P, Gullick N
Other Contributors
Publication date
2022
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Not available
Citation
Gaffney K, Kiltz U, Sfikakis P, Gullick N, et al. Impact immediate treatment interruption of secukinumab efficacy in patients with active psoriatic arthritis and ankylosing spondylitis: interim analysis results from the SERENA study. Rheumatology 61(s1) April 2022
Type
Article